Barclays Raises Price Target and Estimates on Vitamin Shoppe (VSI); Can One Quarter Make A Trend?
Tweet
Share
E-mailGet Alerts VSI Hot Sheet
Price: $6.50 --0%
Rating Summary:
2 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Vitamin Shoppe (NYSE: VSI) price target raised from $44 to $52.
Analyst, Meredith Adler, said, "We never like to say that say one quarter makes a trend, but it seems to us that VSI hit a positive inflection point in 1Q12. Comps rose 9.6%, a real acceleration from the ~7% of the past two years, despite a tough comparison of 8.1% in 1Q11. Sales from e-commerce were also up a strong 15.5% compared to the 11.3% average for all of 2011. This success is not a result of luck or of the industry's robust growth."
Adler thinks VSI has been taking the appropriate steps in e-commerce and social media, however, after yesterday's jump in share price, the stock is fairly valued. Alder raises Q2 EPS from $0.48 to $0.53, FY12 from $1.82 to $1.96 and FY13 from $2.20 to $2.39.
For an analyst ratings summary and ratings history on Vitamin Shoppe click here. For more ratings news on Vitamin Shoppe click here.
Shares of Vitamin Shoppe closed at $51.61 yesterday.
Analyst, Meredith Adler, said, "We never like to say that say one quarter makes a trend, but it seems to us that VSI hit a positive inflection point in 1Q12. Comps rose 9.6%, a real acceleration from the ~7% of the past two years, despite a tough comparison of 8.1% in 1Q11. Sales from e-commerce were also up a strong 15.5% compared to the 11.3% average for all of 2011. This success is not a result of luck or of the industry's robust growth."
Adler thinks VSI has been taking the appropriate steps in e-commerce and social media, however, after yesterday's jump in share price, the stock is fairly valued. Alder raises Q2 EPS from $0.48 to $0.53, FY12 from $1.82 to $1.96 and FY13 from $2.20 to $2.39.
For an analyst ratings summary and ratings history on Vitamin Shoppe click here. For more ratings news on Vitamin Shoppe click here.
Shares of Vitamin Shoppe closed at $51.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
